HALO logo
halo search icon
Kiniksa Pharmaceuticals International, plc Class A
Kiniksa Pharmaceuticals International, plc Class A
KNSA · NAS

Kiniksa Pharmaceuticals International, plc Class A

US$53.65

Price Arrow-0.63 (-1.161%)
21/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusDefying GravityHALO AllHALO Balance SheetHALO Price Momentum
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Kiniksa Pharmaceuticals International, plc Class A Overview

KNSA Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Strong

Earnings

Very Weak

Growth

Earnings

Neutral

Dividends

Very Weak

Quality

Capital Efficiency

Strong

Balance Sheet

Very Strong

About KNSA

icon

Telephone

44.781.431.9100

icon

Address

2nd Floor, 105 Piccadilly, London, Greater London W1J 7NJ

Description

Kiniksa Pharmaceuticals International Plc is a commercial-stage biopharmaceutical company. It engages in discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need. The company was founded on April 9, 2024 and is headquartered in London, United Kingdom.

KNSA Price Chart

Key Stats

Market Cap

US$2.51B

PE

55.20

EV/EBITDA

36.1

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 25.7 - 59.87

Trade Value (12mth)

US$6,038,306.00

1 week

-3.95%

1 month

26.12%

YTD

29.22%

1 year

109.17%

All time high

59.87

Key Fundamentals

EPS 3 yr Growth

-69.90%

EBITDA Margin

11.60%

Operating Cashflow

$138m

Free Cash Flow Return

27.00%

ROIC

11.60%

Interest Coverage

0.00

Quick Ratio

3.40

Other Data

Shares Outstanding (Fully Diluted)

82m

HALO Sector

Healthcare

Next Company Report Date

02-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

KNSA Announcements

Latest Announcements

DateAnnouncements
02 May 26
02 May 26
29 April 26
29 April 26
28 April 26

KNSA Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklock0.2-0.60.8locklocklock
EPS (Fully Diluted)
$locklocklocklock0.2-0.60.75locklocklock
Growth
%locklocklocklock-92.4-400.8231.5locklocklock
PE
Xlocklocklocklock89.6N/A55.2locklocklock
EV/EBITDA
XlocklocklocklockN/AN/A36.1locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS)?
Halo FAQ
The current share price of Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) is USD$53.65.
What is the 52-week high share price for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS)?
Halo FAQ
The 52-week high share price for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) is USD$59.87.
What is the 52-week low share price for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS)?
Halo FAQ
The 52-week low share price for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) is USD$25.70.
What is the dividend yield for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS)?
Halo FAQ
Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) does not pay a dividend.
What was Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) last dividend payment?
Halo FAQ
Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) does not pay a dividend.
What is the franking level for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS)?
Halo FAQ
Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) has a franking level of 0.00%.
In which sector is Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) classified?
Halo FAQ
Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) is classified in the Healthcare.
What is the price-to-earnings (P/E) ratio for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS)?
Halo FAQ
The current P/E ratio for Kiniksa Pharmaceuticals International, plc Class A (KNSA:NAS) is 55.20.

See beyond the curve.

One solution for research, investing and portfolio management.